Search

everythinglearnresearchcommunity

for

Search:↓

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

Washing test helps identify hair loss type, low iron levels significant.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

More atypical club hairs may indicate Telogen Effluvium.

Hair in the front part of the scalp is more likely to fall out than hair in the back in acute telogen effluvium.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Low iron levels are linked to hair loss in women.

Low vitamin D levels may cause hair loss in women.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

The document says that there are treatments for hair and nail diseases.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Higher iron levels in the blood are not linked to increased hair loss in women.